Skip to main content

Anthony Mattacchione, Gerald Herman

Bruker said that Anthony Mattacchione will resign as chief financial officer and senior VP, effective Mar. 16, 2018. Mattacchione has accepted a position as CFO of Albany Molecular Research, commencing in April 2018. Gerald Herman, currently vice president and corporate controller at Bruker, will also serve as Bruker's principal accounting officer, effective immediately. Herman joined the firm in 2016 as VP and corporate controller. Prior to that, he served as corporate VP of clinical operations of Parexel from 2014 to February 2016, and before that, corporate VP of Parexel from 2008 to 2013. Herman has also served as VP-corporate controller of Presstek.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.